AI drug discovery | pharmaphorum

Friday 27 February 2026

AI drug discovery

Digital

pharmaphorum podcast Episode 236, Tarek Samad, Lundbeck

An AI supercomputer and discovering next-gen brain disorder ...

Tarek Samad, Lundbeck’s senior vice president and head of research, discusses AI – specifically, Lundbeck’s agreement with the DCAI to operate Gefion.

Digital

health technology

AI medicines are coming: Building the foundations for discov...

Digital

Eric Luellen and Jonah Comstock interview at AAPS

AI-powered drug discovery is outpacing regulators, with Eric...

During the AAPS National Biotech Conference 2025, pharmaphorum’s Jonah Comstock sat down with Eric Luellen, the founder and CTIO of Turing Biosciences

Digital

unlock AI data

AI and trusted data: The key to unlocking faster, more cost-...

The artificial intelligence (AI) landscape is evolving at a rapid pace.

Digital

pharmaphorum podcast Episode 149a, young lady listening to headphones on a train while looking out the window

Structuring the unstructured: Deterministic AI and white box...

Speed and safety in drug development and discovery represent some of the biggest challenges and opportunities facing life sciences companies today.

R&D

AI tools

Sponsored

Patentability and predictability in AI-assisted drug discove...

Artificial intelligence (AI) and machine learning (ML) are ushering in a new era in drug discovery.